Holen Sie sich die Stockscreener-App
10.72
0.00%
0.00
Handel nachbörslich:
10.74
0.02
+0.19%
Translational Development Acquisition Corp Aktie (TDAC) Neueste Nachrichten
ProLogium’s public listing is set to close in the second half of 2026 — valuing the only mass-production solid-state battery line on Earth at about $3.8 billion - MSN
TDACW Warrants Hold Steady at $1.55 as Trading Range TightensRounding Top - newsline.com
ProLogium to list on Nasdaq via TDAC merger at $3.8B valuation - MSN
Translational Development Acquisition Corp. Warrants (TDACW) Surge 10.71% on Renewed Speculative InterestCommon Gap - newsline.com
ProLogium details tech, 800k cells shipped and TDAC tie‑up (TDAC) - Stock Titan
Linden Advisors/Linden GP disclose 950,000-share stake in TDAC (TDAC) - Stock Titan
Battery maker ProLogium to list on Nasdaq in $3.8 billion SPAC deal - MSN
Number of shareholders of Translational Development Acquisition Corp. – NASDAQ:TDACW - TradingView
ProLogium Set for Nasdaq Debut in $3.8 Billion SPAC Deal - Electric Cars Report
Solid-state battery pioneer ProLogium to go public in $3.8 billion deal - MSN
Leapfrog Acquisition holds near $10 with SPAC deadline on the horizon - Bez Kabli
ProLogium: $3.8 Billion SPAC Deal To Take Solid-State Battery Developer Public On Nasdaq - Pulse 2.0
TDAC (TDAC) CEO Michael Hoffman purchases 53,395 company warrants in open market - Stock Titan
Scanianew under-cab battery module and Megawatt Charging System now available for order - Batteries News
McKinley Acquisition Stock Flat at $10 as $176.7M Deal Waits - Bez Kabli
Imperii Acquisition hovers at $10 as SPAC traders turn their focus back - Bez Kabli
Aldel Financial II Stock Barely Moves, But Its SPAC Clock Is Ticking - Bez Kabli
Translational Development Acquisition Corp. Warrants (TDACW) Surge 7.84% as Bulls Test ResistancePut Flow Alert - The Legal Advocate
RF Acquisition Corp III Trades Around $10 as SPAC Deals Spotlight RFAM - Bez Kabli
ProLogium targets SPAC merger to fund French battery plant - electrive.com
ProLogium to go public via SPAC merger at $3.8B valuation - Investing.com UK
SC II Acquisition Stock Stays Flat as $10 Price Holds Attention - Bez Kabli
ProLogium to go public via SPAC merger at $3.8B valuation By Investing.com - Investing.com India
Translational Development (TDAC) plans SPAC merger deadline extension vote - Stock Titan
3 Firms Steer Battery Maker ProLogium's $3.8B SPAC Merger - Law360
Another solid-state EV battery maker is going public to fund its next growth stage - Electrek
Prologium Holdings Inc. agreed to acquire Translational Development Acquisition Corp. (NasdaqGM:TDAC.U) from TDAC Partners LLC for approximately $3.8 billion in a reverse merger transaction. - marketscreener.com
Solid-state battery maker ProLogium to go public in $3.8 billion deal - Automotive News
Translational Development Acquisition, ProLogium to Combine in $3.8 Billion Transaction - Moomoo
Translational Development Acquisition, ProLogium Announce Nasdaq Merger - TipRanks
ProLogium Picks A SPAC Route To List In New York - Finimize
Translational Development Acquisition to Merge With ProLogium in SPAC Deal Valuing Target at $3.8 Billion - TradingView
TDAC merges with ProLogium, combined company to list as PRLG (PRLG) - Stock Titan
Solid-state battery maker ProLogium, TDAC (NASDAQ: TDAC) plan $3.8B merger - Stock Titan
ProLogium, a Next Generation Solid-State Battery Developer - GlobeNewswire
BreezeBio Announces Scientific Advisory Board to Support Next Stage of Precision Genetic Medicine Pi - pharmiweb.com
BreezeBio Forms Scientific Advisory Board as Precision Genetic Medicine Pipeline Advances - citybiz
Translational Development Acquisition Corp. (TDAC) Edges Lower, Consolidates Near Key SupportPro Level Trade Signals - Newser
Translational Development Acquisition Corp. (TDAC) Holds Steady Near Resistance as Trading Volume Remains MutedMcClellan Summation - Newser
BlossomHill Therapeutics Expands Board of Directors with the Appointments of Sheila Gujrathi, M.D., and John Schmid - The Manila Times
Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer - NTB Kommunikasjon
TRIANA Biomedicines Adds Veteran Drug Developer Mohan Bala as COO Amid Molecular Glue Push - citybiz
0.00%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):